SCHEMBL7345542

SCHEMBL7345542

COc1ccc2nc[nH]c2c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.45
RAD52 P43351 1/20 0.45
RIN1 Q13671 1/20 0.45
MMP12 P39900 1/20 0.43
BRD4 O60885 3/20 0.41
QPCT Q16769 2/20 0.40
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
KMT2A Q03164 1/20 0.38
PDPK1 O15530 1/20 0.37
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13137278 0.80 PTK6 (0.42) ABL1RAD52RIN1MMP12BRD4
SCHEMBL6581871 0.77 PRKCI (0.41) RAD52MMP12MAPTKDM4EMEN1
SCHEMBL29503821 0.76 PARP1 (0.39) RAD52MMP12BRD4MAPTSMN1; SMN2
SCHEMBL3156088 0.76 PARP1 (0.39) RAD52MMP12BRD4MAPTSMN1; SMN2
SCHEMBL3082549 0.76 ABL1 (0.54) ABL1RAD52RIN1MMP12BRD4
SCHEMBL31538912 0.74 ABL1 (0.53) ABL1RAD52RIN1MMP12BRD4
SCHEMBL1798450 0.73 PARP1 (0.37) RAD52MMP12BRD4QPCTMAPT
SCHEMBL7348969 0.73 PARP1 (0.37) RAD52MMP12MAPTSMN1; SMN2KDM4E
SCHEMBL1374558 0.72 PRKCI (0.44) RAD52MMP12MAPTSMN1; SMN2KDM4E
SCHEMBL17033192 0.71 MAP4K1 (0.38) ABL1RAD52RIN1MMP12BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed